{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:19:25Z","timestamp":1777389565181,"version":"3.51.4"},"reference-count":103,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Acne vulgaris is a universal multifactorial human skin condition of the pilosebaceous units.\nAlthough acne majorly prevails in teenagers, it is neither restricted to age group nor gender. Multifarious\ncausative factors like Propionibacterium acnes, dysregulated sebum secretion, and androgens play\nan integral role in the manifestation of acne. Though abundant new chemical entities are convenient for\nacne therapy, none can treat this condition without compromising patient compliance. Furthermore,\naccessible treatment prevents the ailment and alleviates signs and symptoms with no absolute cure. So\npresently, despite the variety of topical formulations, the current market demands an ideal remedy to\nfulfill the unmet need for acne management. Extensive research has proved the upper hand of novel\ncarrier systems over conventional formulations by substantially improving efficacy and eliminating\nunpleasant side effects. Lipid-based vesicular and particulate systems are promising prospects due to\ntheir closeness to the intrinsic structure of the skin, which offer delivery of the actives in a more desirable\napproach. This review underlines the practicability and superiority of liposomes, niosomes, transfersomes,\nethosomes, cubosomes, solid lipid nanoparticles, and nanostructured lipid carriers over conventional\ntherapies for acne. The review also highlights acne product market survey and available conventional\nas well as novel formulations portraying their scope in the market. In a nutshell, lipid-based vesicular\nand particulate systems prevail as a propitious modality for treating acne vulgaris as they conduce\nbetter penetrability, localized action, and reduce adverse effects. These systems have the ability to\nopen a window of opportunities for effective acne alleviation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201819666220524154448","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:35:20Z","timestamp":1653471320000},"page":"57-74","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insights of Lipid Vesicular and Particulate Carrier Mediated Approach\nfor Acne Management"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-8450","authenticated-orcid":true,"given":"Prachi","family":"Pimple","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-0118","authenticated-orcid":true,"given":"Shruti","family":"Dudhat","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-5799","authenticated-orcid":true,"given":"Prabha","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/21691401.2014.916715","volume":"44","author":"Garg T.","year":"2016","unstructured":"Garg T.; Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 2016,44(1),98-105","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1468-3083.2010.03919.x","volume":"25","author":"Perkins A.C.","year":"2011","unstructured":"Perkins A.C.; Cheng C.E.; Hillebrand G.G.; Miyamoto K.; Kimball A.B.; Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011,25(9),1054-1060","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1468-2494.2011.00647.x","volume":"33","author":"Kanlayavattanakul M.","year":"2011","unstructured":"Kanlayavattanakul M.; Lourith N.; Therapeutic agents and herbs in topical application for acne treatment. Int J Cosmet Sci 2011,33(4),289-297","journal-title":"Int J Cosmet Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40257-017-0321-x","volume":"19","author":"Clark A.K.","year":"2018","unstructured":"Clark A.K.; Saric S.; Sivamani R.K.; Acne scars: How do we grade them? Am J Clin Dermatol 2018,19(2),139-144","journal-title":"Am J Clin Dermatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0738-3991(03)00168-X","volume":"54","author":"Brajac I.","year":"2004","unstructured":"Brajac I.; Bili\u0107-Zulle L.; Tkalci\u0107 M.; Lon&#x10D;arek K.; Gruber F.; Acne vulgaris: Myths and misconceptions among patients and family physicians. Patient Educ Couns 2004,54(1),21-25","journal-title":"Patient Educ Couns"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-49274-2","author":"Plewig G.","year":"2019","unstructured":"Plewig G.; Melnik B.; Chen W.;  Plewig and Kligman\u2019s Acne and Rosacea 2019","journal-title":"Plewig and Kligman\u2019s Acne and Rosacea"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijwd.2017.10.006","volume":"4","author":"Tan A.U.","year":"2017","unstructured":"Tan A.U.; Schlosser B.J.; Paller A.S.; A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol 2017,4(2),56-71","journal-title":"Int J Womens Dermatol"},{"key":"ref=8","year":"2018-2025","unstructured":"Acne Drugs Market Size  Available from:  (accessed Nov. 17, 2020).2018-2025","journal-title":"Acne Drugs Market Size"},{"key":"ref=9","first-page":"2021","unstructured":"Anti-acne Cosmetics Market Size  Available from: ,2021-2028","journal-title":"Anti-acne Cosmetics Market Size"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/derm.1.2.7804","volume":"1","author":"Zouboulis C.C.","year":"2009","unstructured":"Zouboulis C.C.; Sebaceous gland receptors. Dermatoendocrinol 2009,1(2),77-80","journal-title":"Dermatoendocrinol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","volume":"30","author":"B&#xED;r&#xF3; T.","year":"2009","unstructured":"B&#xED;r&#xF3; T.; T&#xF3;th B.I.; Hask&#xF3; G.; Paus R.; Pacher P.; The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 2009,30(8),411-420","journal-title":"Trends Pharmacol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14374","volume":"31","author":"Dr&#xE9;no B.","year":"2017","unstructured":"Dr&#xE9;no B.; What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol 2017,31(Suppl. 5),8-12","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/molecules21081063","volume":"21","author":"Fox L.","year":"2016","unstructured":"Fox L.; Csongradi C.; Aucamp M.; du Plessis J.; Gerber M.; Treatment modalities for acne. Molecules 2016,21(8),8","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","volume":"14","author":"Solomon C.G.","year":"2018","unstructured":"Solomon C.G.; Zaenglein A.L.; Clinical practice acne vulgaris. N Engl J Med 2018,14(14),1343-1352","journal-title":"N Engl J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2014.05.054","volume":"193","author":"Zhai Y.","year":"2014","unstructured":"Zhai Y.; Zhai G.; Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release 2014,193,90-99","journal-title":"J Control Release"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fphar.2015.00219","volume":"6","author":"Hua S.","year":"2015","unstructured":"Hua S.; Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol 2015,6,219","journal-title":"Front Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","volume":"535","author":"Sala M.","year":"2018","unstructured":"Sala M.; Diab R.; Elaissari A.; Fessi H.; Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Int J Pharm 2018,535(1-2),1-17","journal-title":"Int J Pharm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"Gollnick H.","year":"2003","unstructured":"Gollnick H.; Cunliffe W.; Berson D.; Dreno B.; Finlay A.; Leyden J.J.; Shalita A.R.; Thiboutot D.; Management of acne: A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003,49(1)(Suppl.),S1-S37","journal-title":"J Am Acad Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s40265-019-01218-6","volume":"79","author":"Scott L.J.","year":"2019","unstructured":"Scott L.J.; Trifarotene: First Approval. Drugs 2019,79(17),1905-1909","journal-title":"Drugs"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","volume":"63","author":"Gollnick H.","year":"2003","unstructured":"Gollnick H.; Current concepts of the pathogenesis of acne: Implications for drug treatment. Drugs 2003,63(15),1579-1596","journal-title":"Drugs"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e25580","DOI":"10.5812\/jjm.25580","volume":"8","author":"Nasri H.","year":"2015","unstructured":"Nasri H.; Bahmani M.; Shahinfard N.; Moradi Nafchi A.; Saberianpour S.; Rafieian Kopaei M.; Medicinal plants for the treatment of acne vulgaris: A review of recent evidences. Jundishapur J Microbiol 2015,8(11),e25580","journal-title":"Jundishapur J Microbiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"276260","DOI":"10.1155\/2014\/276260","volume":"2014","author":"Vyas A.","year":"2014","unstructured":"Vyas A.; Kumar Sonker A.; Gidwani B.; Carrier-based drug delivery system for treatment of acne. ScientificWorldJournal 2014,2014,276260","journal-title":"ScientificWorldJournal"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"801820","DOI":"10.1155\/2014\/801820","volume":"2014","author":"Shrestha H.","year":"2014","unstructured":"Shrestha H.; Bala R.; Arora S.; Lipid-based drug delivery systems. J Pharm (Cairo) 2014,2014,801820","journal-title":"J Pharm (Cairo)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000089138","volume":"19","author":"Date A.A.","year":"2006","unstructured":"Date A.A.; Naik B.; Nagarsenker M.S.; Novel drug delivery systems: Potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006,19(1),2-16","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1517\/17425247.2013.746310","volume":"10","author":"Hamishehkar H.","year":"2013","unstructured":"Hamishehkar H.; Rahimpour Y.; Kouhsoltani M.; Niosomes as a propitious carrier for topical drug delivery. Expert Opin Drug Deliv 2013,10(2),261-272","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=26","first-page":"2","volume":"6","author":"Rai A.K.","year":"2017","unstructured":"Rai A.K.; Alam G.; Singh A.P.; Verma N.K.; Niosomes&#x202F;: An approach to current drug delivery-A review. Int J Adv Pharm 2017,6(2),2","journal-title":"Int J Adv Pharm"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/1567201813666160520114436","volume":"14","author":"Garg V.","year":"2017","unstructured":"Garg V.; Singh H.; Bimbrawh S.; Singh S.K.; Gulati M.; Vaidya Y.; Kaur P.; Ethosomes and transfersomes: Principles, perspectives and practices. Curr Drug Deliv 2017,14(5),613-633","journal-title":"Curr Drug Deliv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"Opatha S.A.T.","year":"2020","unstructured":"Opatha S.A.T.; Titapiwatanakun V.; Chutoprapat R.; Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020,12(9),9","journal-title":"Pharmaceutics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.22270\/ujpr.v2i4.RW2","volume":"2","author":"Chauhan N.","year":"2017","unstructured":"Chauhan N.; Kumar K.; Pant N.; An updated review on transfersomes: A novel vesicular system for transdermal drug delivery. Univers J Pharm Res 2017,2(4),49-52","journal-title":"Univers J Pharm Res"},{"key":"ref=30","first-page":"226","volume":"1","author":"Grace F.","year":"2014","unstructured":"Grace F.; Herbal ethosomes- A novel approach in herbal drug technology. Am J Ethnomedicine 2014,1(4),226-230","journal-title":"Am J Ethnomedicine"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0110-5558.72415","volume":"1","author":"Verma P.","year":"2010","unstructured":"Verma P.; Pathak K.; Therapeutic and cosmeceutical potential of ethosomes: An overview. J Adv Pharm Technol Res 2010,1(3),274-282","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=32","first-page":"354","volume":"4","author":"Aggarwal D.","year":"2016","unstructured":"Aggarwal D.; Nautiyal U.; Ethosomes: A review. Int J Pharm Med Res 2016,4(4),354-363","journal-title":"Int J Pharm Med Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/jabps.2019.16887.1057","volume":"3","author":"Armia S.","year":"2020","unstructured":"Armia S.; Garhy O.; Abdelkader H.; Cubosomes: Composition, preparation, and drug delivery applications. J Adv Biomed Pharm Sci 2020,3(1),1-9","journal-title":"J Adv Biomed Pharm Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.33263\/BRIAC114.1203712054","volume":"11","author":"Chettupalli A.K.","year":"2020","unstructured":"Chettupalli A.K.; Ananthula M.; Amarachinta P.R.; Bakshi V.; Yata V.K.; Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface Res Appl Chem 2020,11(4),12037-12054","journal-title":"Biointerface Res Appl Chem"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2016.05.119","author":"Geszke-Moritz M.","year":"2016","unstructured":"Geszke-Moritz M.; Moritz M.;  Solid Lipid Nanoparticles as Attractive Drug Vehicles: Composition, Properties and Therapeutic Strategies 2016","journal-title":"Solid Lipid Nanoparticles as Attractive Drug Vehicles: Composition, Properties and Therapeutic Strategies"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"Pardeike J.","year":"2009","unstructured":"Pardeike J.; Hommoss A.; M&#xFC;ller R.H.; Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009,366(1-2),170-184","journal-title":"Int J Pharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0378-5173(02)00684-1","volume":"254","author":"Wissing S.A.","year":"2003","unstructured":"Wissing S.A.; M&#xFC;ller R.H.; Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 2003,254(1),65-68","journal-title":"Int J Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-3-030-44921-6_5","volume":"Vol. 2","author":"Kassem A.A.","year":"2021","unstructured":"Kassem A.A.; Abd El-Alim S.H.; Vesicular nanocarriers: A potential platform for dermal and transdermal drug delivery. Nanopharmaceuticals: Principles and Applications 2021,Vol. 2,155-209","journal-title":"Nanopharmaceuticals: Principles and Applications"},{"key":"ref=39","author":"Jain N.K.","year":"2013","unstructured":"Jain N.K.;  Controlled and Novel Drug Delivery 2013","journal-title":"Controlled and Novel Drug Delivery"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3109\/03639045.2015.1082580","volume":"42","author":"Kumar V.","year":"2016","unstructured":"Kumar V.; Banga A.K.; Intradermal and follicular delivery of adapalene liposomes. Drug Dev Ind Pharm 2016,42(6),871-879","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2217\/nnm-2018-0002","volume":"13","author":"Jain S.","year":"2018","unstructured":"Jain S.; Kale D.P.; Swami R.; Katiyar S.S.; Codelivery of benzoyl peroxide","journal-title":"Nanomedicine (Lond)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/08982104.2019.1630646","volume":"30","author":"Ero&#x11F;lu \u0130.","year":"2020","unstructured":"Ero&#x11F;lu \u0130.; Liposome-based combination therapy for acne treatment. J Liposome Res 2020,30(3),263-273","journal-title":"J Liposome Res"},{"key":"ref=43","author":"Bhardwaj A.","unstructured":"Bhardwaj A.; Kori M.; Formulation development and evaluation of topical liposomal gel for management of acne."},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/jocd.12340","volume":"16","author":"Fabbrocini G.","year":"2017","unstructured":"Fabbrocini G.; Capasso C.; Donnarumma M.; Cantelli M.; Le Ma&#xEE;tre M.; Monfrecola G.; Emanuele E.; A peel-off facial mask comprising myoinositol and trehalose-loaded liposomes improves adult female acne by reducing local hyperandrogenism and activating autophagy. J Cosmet Dermatol 2017,16(4),480-484","journal-title":"J Cosmet Dermatol"},{"key":"ref=45","first-page":"8","volume":"4","author":"Tripura Sundari P.","year":"2017","unstructured":"Tripura Sundari P.; Anushree H.; Novel delivery systems: Current trend in cosmetic industry. Eur J Pharm Med Res 2017,4(8),8","journal-title":"Eur J Pharm Med Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/RRTD.S64773","volume":"4","author":"Muzzalupo R.","year":"2015","unstructured":"Muzzalupo R.; Tavano L.; Niosomal drug delivery for transdermal targeting: Recent advances. Res Rep Transdermal Drug Deliv 2015,4,23-33","journal-title":"Res Rep Transdermal Drug Deliv"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/10717544.2013.855277","volume":"22","author":"Goyal G.","year":"2015","unstructured":"Goyal G.; Garg T.; Malik B.; Chauhan G.; Rath G.; Goyal A.K.; Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv 2015,22(8),1027-1042","journal-title":"Drug Deliv"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2011\/503158","volume":"2011","author":"Vyas J.","year":"2011","unstructured":"Vyas J.; Vyas P.; Raval D.; Paghdar P.; Development of topical niosomal gel of benzoyl peroxide. ISRN Nanotechnol 2011,2011(1996),1-6","journal-title":"ISRN Nanotechnol"},{"key":"ref=49","first-page":"1714","volume":"3","author":"Jigar V.","year":"2011","unstructured":"Jigar V.; Vishal G.; Tejas G.; Vishal C.; Umesh U.; Formulation and characterization of topical gel of erythromycin entrapped into nio-somesfile:\/\/\/F:\/MPharm\/Niosomes\/Niosomal Gel of Benzoyl Peroxide.pdf. Int J Pharm Tech Res 2011,3(3),1714-1718","journal-title":"Int J Pharm Tech Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3109\/10717544.2014.903010","volume":"22","author":"Budhiraja A.","year":"2015","unstructured":"Budhiraja A.; Dhingra G.; Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv 2015,22(6),723-730","journal-title":"Drug Deliv"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1517\/17425247.3.6.727","volume":"3","author":"Benson H.A.","year":"2006","unstructured":"Benson H.A.; Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 2006,3(6),727-737","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1208\/s12249-019-1518-5","volume":"21","author":"Vasanth S.","year":"2020","unstructured":"Vasanth S.; Dubey A.; Ravi G.S.; Lewis S.A.; Ghate V.M.; El-Zahaby S.A.; Hebbar S.; Development and investigation of vitamin c-enriched adapalene-loaded transfersome gel: A collegial approach for the treatment of acne vulgaris. AAPS PharmSciTech 2020,21(2),61","journal-title":"AAPS PharmSciTech"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1208\/s12249-015-0441-7","volume":"17","author":"Abdellatif A.A.H.","year":"2016","unstructured":"Abdellatif A.A.H.; Tawfeek H.M.; Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin. AAPS PharmSciTech 2016,17(5),1067-1074","journal-title":"AAPS PharmSciTech"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.22270\/jddt.v8i5.1826","volume":"8","author":"Thakur N.","year":"2018","unstructured":"Thakur N.; Jain P.; Jain V.; Formulation development and evaluation of transferosomal gel. J Drug Deliv Ther 2018,8(5),5","journal-title":"J Drug Deliv Ther"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/08982104.2018.1517160","volume":"29","author":"Nainwal N.","year":"2019","unstructured":"Nainwal N.; Jawla S.; Singh R.; Saharan V.A.; Transdermal applications of ethosomes - a detailed review. J Liposome Res 2019,29(2),103-113","journal-title":"J Liposome Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jddst.2018.11.016","volume":"49","author":"Kausar H.","year":"2019","unstructured":"Kausar H.; Mujeeb M.; Ahad A.; Moolakkadath T.; Aqil M.; Ahmad A.; Akhter M.H.; Optimization of ethosomes for topical thymoquinone delivery for the treatment of skin acne. J Drug Deliv Sci Technol 2019,49,177-187","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.5530\/ijper.50.3.34","volume":"50","author":"Mistry A.","year":"2016","unstructured":"Mistry A.; Ravikumar P.; Development and evaluation of azelaic acid based ethosomes for topical delivery for the treatment of acne. Indian J Pharm Educ Res 2016,50(3s),S232-S243","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e0159967","DOI":"10.1371\/journal.pone.0159967","volume":"11","author":"Yu Z.","year":"2016","unstructured":"Yu Z.; Lv H.; Han G.; Ma K.; Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One 2016,11(7),e0159967","journal-title":"PLoS One"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.drudis.2016.01.004","volume":"21","author":"Karami Z.","year":"2016","unstructured":"Karami Z.; Hamidi M.; Cubosomes: Remarkable drug delivery potential. Drug Discov Today 2016,21(5),789-801","journal-title":"Drug Discov Today"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jddst.2018.09.002","volume":"48","author":"Nithya R.","year":"2018","unstructured":"Nithya R.; Jerold P.; Siram K.; Cubosomes of dapsone enhanced permeation across the skin. J Drug Deliv Sci Technol 2018,48,75-81","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/2211738506666180209100222","volume":"6","author":"Jain A.","year":"2018","unstructured":"Jain A.; Topical delivery of erythromycin through cubosomes for acne. Pharm Nanotechnol 2018,6(1),38-47","journal-title":"Pharm Nanotechnol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1081\/DDC-100107251","volume":"27","author":"Patel V.B.","year":"2001","unstructured":"Patel V.B.; Misra A.N.; Marfatia Y.S.; Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev Ind Pharm 2001,27(8),863-869","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"E-TN4","DOI":"10.1208\/pt0203_tn4","volume":"2","author":"Patel V.","year":"2001","unstructured":"Patel V.; Misra A.; Marfatia Y.; Clinical assessment of the combination therapy with liposomal gels of tretinoin and benzoyl peroxide in acne. AAPS PharmSciTech 2001,2(3),E-TN4","journal-title":"AAPS PharmSciTech"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1007\/s004240000000","volume":"440","author":"Honzak L.","year":"2000","unstructured":"Honzak L.; \u0160entjurc M.; Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Archiv 2000,440(Suppl. 5),R44-R45","journal-title":"Pflugers Archiv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijpharm.2005.01.012","volume":"293","author":"Ioele G.","year":"2005","unstructured":"Ioele G.; Cione E.; Risoli A.; Genchi G.; Ragno G.; Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int J Pharm 2005,293(1-2),251-260","journal-title":"Int J Pharm"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1081\/DDC-120018380","volume":"29","author":"Bhalerao S.S.","year":"2003","unstructured":"Bhalerao S.S.; Raje Harshal A.; Preparation, optimization, characterization, and stability studies of salicylic acid liposomes. Drug Dev Ind Pharm 2003,29(4),451-467","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1081\/PDT-100102029","volume":"5","author":"Patel V.B.","year":"2000","unstructured":"Patel V.B.; Misra A.; Marfatia Y.S.; Topical liposomal gel of tretinoin for the treatment of acne: Research and clinical implications. Pharm Dev Technol 2000,5(4),455-464","journal-title":"Pharm Dev Technol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0378-5173(03)00268-0","volume":"260","author":"Manconi M.","year":"2003","unstructured":"Manconi M.; Valenti D.; Sinico C.; Lai F.; Loy G.; Fadda A.M.; Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003,260(2),261-272","journal-title":"Int J Pharm"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2005.11.045","volume":"311","author":"Manconi M.","year":"2006","unstructured":"Manconi M.; Sinico C.; Valenti D.; Lai F.; Fadda A.M.; Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006,311(1-2),11-19","journal-title":"Int J Pharm"},{"key":"ref=70","first-page":"65","volume":"1","author":"Patel R.P.","year":"2011","unstructured":"Patel R.P.; Patel K.P.; Modi K.A.; Pathak C.J.; Novel anti-acne drug delivery system of tretinoin. Intl R J Pharm 2011,1(2),65-71","journal-title":"Intl R J Pharm"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.20959\/wjpr20176-8494","volume":"6","author":"Gupta M.","year":"2017","unstructured":"Gupta M.; Prajapati R.N.; Singh N.; Prajapati S.K.; Novel clindamycin loaded transfersomes formulation for effective management of acne. World J Pharm Res 2017,6(6),765-773","journal-title":"World J Pharm Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4274\/tjps.galenos.2019.98624","volume":"18","author":"Nangare S.","year":"2021","unstructured":"Nangare S.; Bhatane D.; Mali R.; Shitole M.; Development of novel freeze-dried mulberry leaves extract-based transfersomal gel. Turk J Pharm Sci 2021,18(1),44-55","journal-title":"Turk J Pharm Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/japtr.JAPTR_289_18","volume":"10","author":"Apriani E.F.","year":"2019","unstructured":"Apriani E.F.; Rosana Y.; Iskandarsyah I.; Formulation, characterization, and in vitro testing of azelaic acid ethosome-based cream against Propionibacterium acnes for the treatment of acne. J Adv Pharm Technol Res 2019,10(2),75-80","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.26452\/ijrps.v11i4.3185","volume":"11","author":"Sandhya P.","year":"2020","unstructured":"Sandhya P.; Snehalata J.; Formulation development and evaluation of antiacne activity of ethosomal gel prepared using Plumbago zeylanica root extract. Int J Res Pharm Sci 2020,11(4),5511-5516","journal-title":"Int J Res Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14499\/indonesianjpharm27iss1pp44","volume":"27","author":"Venugopal V.","year":"2016","unstructured":"Venugopal V.; Formulation development and characterization of tea tree oil loaded ethosomes. Indones J Pharm 2016,27(1),44","journal-title":"Indones J Pharm"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.22270\/jddt.v8i5-s.1982","volume":"8","author":"Mishra R.","year":"2018","unstructured":"Mishra R.; Shende S.; Jain P.K.; Jain V.; Formulation and evaluation of gel containing ethosomes entrapped with tretinoin. J Drug Deliv Ther Art 2018,8(5-s),315-321","journal-title":"J Drug Deliv Ther Art"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1872211312666180213121117","volume":"12","author":"Sureka S.","year":"2018","unstructured":"Sureka S.; Gupta G.; Agarwal M.; Mishra A.; K Singh S.; P Singh R.; Sah S.K.; de Jesus A.; Pinto T.; Dua K.; Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne. Recent Pat Drug Deliv Formul 2018,12(2),121-129","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejps.2017.11.023","volume":"112","author":"Garc&#xEA;s A.","year":"2018","unstructured":"Garc&#xEA;s A.; Amaral M.H.; Sousa Lobo J. M.; Silva A. C.; Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur J Pharm Sci 2018,112,159-167","journal-title":"Eur J Pharm Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/B978-0-12-814033-8.00008-4","author":"Kumar R.","year":"2019","unstructured":"Kumar R.; Lipid-based nanoparticles for drug-delivery systems. Nanocarriers for Drug Delivery 2019,249-284","journal-title":"Nanocarriers for Drug Delivery"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","volume":"121","author":"Jain A.K.","year":"2014","unstructured":"Jain A.K.; Jain A.; Garg N.K.; Agarwal A.; Jain A.; Jain S.A.; Tyagi R.K.; Jain R.K.; Agrawal H.; Agrawal G.P.; Adapalene loaded solid lipid nanoparticles gel: An effective approach for acne treatment. Colloids Surf B Biointerfaces 2014,121,222-229","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4155\/tde.14.31","volume":"5","author":"Pokharkar V.B.","year":"2014","unstructured":"Pokharkar V.B.; Mendiratta C.; Kyadarkunte A.Y.; Bhosale S.H.; Barhate G.A.; Skin delivery aspects of benzoyl peroxide-loaded solid lipid nanoparticles for acne treatment. Ther Deliv 2014,5(6),635-652","journal-title":"Ther Deliv"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.colsurfb.2012.12.043","volume":"105","author":"Raza K.","year":"2013","unstructured":"Raza K.; Singh B.; Singal P.; Wadhwa S.; Katare O.P.; Systematically optimized biocompatible isotretinoin-loaded Solid Lipid Nanoparti-cles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces 2013,105,67-74","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.colsurfb.2015.02.046","volume":"128","author":"Kelidari H.R.","year":"2015","unstructured":"Kelidari H.R.; Saeedi M.; Akbari J.; Morteza-Semnani K.; Gill P.; Valizadeh H.; Nokhodchi A.; Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces 2015,128,473-479","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1166\/jnn.2015.9184","volume":"15","author":"Silva E.L.","year":"2015","unstructured":"Silva E.L.; Carneiro G.; De Ara&#xFA;jo L.A.; Trindade M.J.; Yoshida M.I.; Or&#xE9;fice R.L.; Farias L.M.; De Carvalho M.A.; Dos Santos S.G.; Goulart G.A.; Alves R.J.; Ferreira L.A.; Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris. J Nanosci Nanotechnol 2015,15(1),792-799","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=85","first-page":"921","volume":"2","author":"Patel D.K.","year":"2013","unstructured":"Patel D.K.; Tripathy S.; Nair S.K.; Kesharwani R.; Nanostructured lipid carrier (NLC) a modern approach for topical delivery: A review. World J Pharm Pharm Sci 2013,2(3),921-938","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/03639045.2015.1104343","volume":"42","author":"Jain A.","year":"2016","unstructured":"Jain A.; Garg N.K.; Jain A.; Kesharwani P.; Jain A.K.; Nirbhavane P.; Tyagi R.K.; A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Drug Dev Ind Pharm 2016,42(6),897-905","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.jddst.2019.101418","volume":"55","author":"Malik D.S.","year":"2020","unstructured":"Malik D.S.; Kaur G.; Exploring therapeutic potential of azelaic acid loaded NLCs for the treatment of acne vulgaris. J Drug Deliv Sci Technol 2020,55,101418","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"101253","DOI":"10.1016\/j.jddst.2019.101253","volume":"54","author":"Fatima N.","year":"2019","unstructured":"Fatima N.; Rehman S.; Nabi B.; Baboota S.; Ali J.; Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. J Drug Deliv Sci Technol 2019,54,101253","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejpb.2016.07.026","volume":"108","author":"Ghate V.M.","year":"2016","unstructured":"Ghate V.M.; Lewis S.A.; Prabhu P.; Dubey A.; Patel N.; Nanostructured lipid carriers for the topical delivery of tretinoin. Eur J Pharm Biopharm 2016,108,253-261","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.colsurfb.2016.05.042","volume":"146","author":"Kelidari H.R.","year":"2016","unstructured":"Kelidari H.R.; Saeedi M.; Hajheydari Z.; Akbari J.; Morteza-Semnani K.; Akhtari J.; Valizadeh H.; Asare-Addo K.; Nokhodchi A.; Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial. Colloids Surf B Biointerfaces 2016,146,47-53","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11095-006-9225-9","volume":"24","author":"Stecov&#xE1; J.","year":"2007","unstructured":"Stecov&#xE1; J.; Mehnert W.; Blaschke T.; Kleuser B.; Sivaramakrishnan R.; Zouboulis C.C.; Seltmann H.; Korting H.C.; Kramer K.D.; Sch&#xE4;fer-Korting M.; Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterisation and skin uptake. Pharm Res 2007,24(5),991-1000","journal-title":"Pharm Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","volume":"328","author":"Liu J.","year":"2007","unstructured":"Liu J.; Hu W.; Chen H.; Ni Q.; Xu H.; Yang X.; Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007,328(2),191-195","journal-title":"Int J Pharm"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2221-6189(13)60144-4","volume":"2","author":"Vijayan V.","year":"2013","unstructured":"Vijayan V.; Aafreen S.; Sakthivel S.; Reddy K.R.; Formulation and characterization of solid lipid nanoparticles loaded Neem oil for topical treatment of acne. J Acute Dis 2013,2(4),282-286","journal-title":"J Acute Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","volume":"363","author":"Mandawgade S.D.","year":"2008","unstructured":"Mandawgade S.D.; Patravale V.B.; Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int J Pharm 2008,363(1-2),132-138","journal-title":"Int J Pharm"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00403-011-1130-3","volume":"303","author":"Castro G.A.","year":"2011","unstructured":"Castro G.A.; Oliveira C.A.; Mahecha G.A.B.; Ferreira L.A.M.; Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res 2011,303(7),513-520","journal-title":"Arch Dermatol Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e14777","DOI":"10.1111\/dth.14777","volume":"34","author":"Ahmad Nasrollahi S.","year":"2021","unstructured":"Ahmad Nasrollahi S.; Koohestani F.; Naeimifar A.; Samadi A.; Vatanara A.; Firooz A.; Preparation and evaluation of adapalene nanostructured lipid carriers for targeted drug delivery in acne. Dermatol Ther 2021,34(2),e14777","journal-title":"Dermatol Ther"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/02726351.2017.1305026","volume":"36","author":"Patwekar S.L.","year":"2018","unstructured":"Patwekar S.L.; Pedewad S.R.; Gattani S.; Development and evaluation of nanostructured lipid carriers-based gel of isotretinoin. Particul Sci Technol 2018,36(7),832-843","journal-title":"Particul Sci Technol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejps.2016.12.020","volume":"99","author":"Kov&#xE1;cs A.","year":"2017","unstructured":"Kov&#xE1;cs A.; Berk&#xF3; S.; Cs&#xE1;nyi E.; Cs&#xF3;ka I.; Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method. Eur J Pharm Sci 2017,99,246-257","journal-title":"Eur J Pharm Sci"},{"key":"ref=99","year":"2020","unstructured":"C for F S and A Nutrition Guidance for industry: Safety of nanomaterials in cosmetic products Available from: 2020","journal-title":"C for F S and A Nutrition Guidance for industry: Safety of nanomaterials in cosmetic products"},{"key":"ref=100","year":"2019","unstructured":"Directorate General for Health and Food Safety Guidance on the safety assessment of nanomaterials in cosmetics European CommissionAvailable from: 2019","journal-title":"Directorate General for Health and Food Safety Guidance on the safety assessment of nanomaterials in cosmetics"},{"key":"ref=101","year":"2019","unstructured":"Considering whether an FDA-regulated product involves the application of nanotechnology US Food and Drug Administration Office of the CommissionerAvailable from: 2019","journal-title":"Considering whether an FDA-regulated product involves the application of nanotechnology US Food and Drug Administration"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","volume":"14","author":"Ragelle H.","year":"2017","unstructured":"Ragelle H.; Danhier F.; Pr&#xE9;at V.; Langer R.; Anderson D.G.; Nanoparticle-based drug delivery systems: A commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv 2017,14(7),851-864","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=103","year":"2020","unstructured":"Nanotechnology\u2014over a decade of progress and innovation: A report by the US food and drug administration Available from: 2020","journal-title":"Nanotechnology\u2014over a decade of progress and innovation: A report by the US food and drug administration"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201819666220524154448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205202\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201819666220524154448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T12:24:06Z","timestamp":1676463846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205202\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201819666220524154448","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}